Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target

preprint OA: closed
Full text JSON View at publisher
Full text 20,768 characters · extracted from preprint-html · click to expand
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target Maria Castro, Felipe Núñez, Kaushik Banerjee, Anzar Mujeeb, Ava Mauser, and 24 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7483444/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted You are reading this latest preprint version Abstract Mutant isocitrate dehydrogenase 1 (mIDH1) catalyzes 2-hydroxyglutarate production which leads to epigenetic reprogramming. RNA-seq, scRNA-seq, and ChIP-seq analysis revealed that human and mouse mIDH1 gliomas exhibit downregulated gene ontologies (GOs) related to mitochondrial metabolism and upregulated autophagy-related GOs. Decreased mitochondrial metabolism was accompanied by decreased glycolysis, rendering autophagy a source of energy in mIDH1 gliomas. Human and mouse mIDH1 glioma cells exhibited increased expression of autophagy-related proteins and enhanced LC3 I/II conversion, indicating augmented autophagy. Inhibiting autophagy in vivo by administration of synthetic protein nanoparticles encapsulating siRNA targeting Atg7 sensitized mIDH1 glioma cells to radiation, resulting in tumor regression, long-term survival, and immunological memory. This work uncovered autophagy as a critical pathway for survival in mIDH1 gliomas and its inhibition elicits radiosensitivity in vitro in human and mouse mIDH1 glioma cells, and in vivo in mIDH1 mouse models. Thus, autophagy inhibition emerges as an attractive therapeutic target for mIDH1 gliomas. Biological sciences/Cancer/CNS cancer Biological sciences/Cancer/Cancer therapy/Radiotherapy Biological sciences/Cancer/Cancer therapy/Targeted therapies Full Text Additional Declarations Yes there is potential Competing Interest. In the past three years, C.A.L. has consulted for Astellas Pharmaceuticals, Odyssey Therapeutics, Third Rock Ventures, and T-Knife Therapeutics, and is an inventor on patents pertaining to Kras regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1-ME1 pathway as a therapeutic approach (US Patent No: 2015126580-A1, 05/07/2015; US Patent No: 20190136238, 05/09/2019; International Patent No: WO2013177426-A2, 04/23/2015). All other authors declare that there is no conflict of interest regarding the publication of this article. Supplementary Files AutophagyTableS1forF1B.xlsx Supplementary Table 1 AutophagyTableS2forF1C.xlsx Supplementary Table 2 AutophagySupplementalmanuscript08.28.25.pdf Supplementary Methods and Figures Cite Share Download PDF Status: Under Review Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7483444","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":512865811,"identity":"c1db8c77-da2d-4011-8c33-03e3fbe4ee1e","order_by":0,"name":"Maria Castro","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAw0lEQVRIiWNgGAWjYJCCAyCCH8RgbIBxidEi2UCKFjAwAKkkSotu+9mHB37U2Nkb38hOPPBzB4Mc340E/FrMzqQbHOw5lpy47UbuhoO9ZxiMJQlqOZDGcIC3gTnBDKjlMGMbQ+IGglrOP2M4+Leh3t54BkRLPWEtN9IYDvM2HGbcIAHRkmBAWMszhsMyx44nzjjzFuiXNgnDmWceEHJYGvPHNzXV9vztuZs//Gyzkec7TsAWdCBBmvJRMApGwSgYBdgBAOxrUA8aTkqOAAAAAElFTkSuQmCC","orcid":"https://orcid.org/0000-0003-2237-2756","institution":"University of Michigan","correspondingAuthor":true,"prefix":"","firstName":"Maria","middleName":"","lastName":"Castro","suffix":""},{"id":512865812,"identity":"87609e6a-181a-4ec9-9193-2e5bd7099997","order_by":1,"name":"Felipe Núñez","email":"","orcid":"","institution":"University of Michigan Medical School","correspondingAuthor":false,"prefix":"","firstName":"Felipe","middleName":"","lastName":"Núñez","suffix":""},{"id":512865813,"identity":"5fb4fc11-59e7-4270-9511-515d6d1b84de","order_by":2,"name":"Kaushik Banerjee","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Kaushik","middleName":"","lastName":"Banerjee","suffix":""},{"id":512865814,"identity":"50de85bb-1f05-43d3-ad15-dca0681122d2","order_by":3,"name":"Anzar Mujeeb","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Anzar","middleName":"","lastName":"Mujeeb","suffix":""},{"id":512865815,"identity":"d03cd2ca-3ed6-4026-a15e-e00f2522273d","order_by":4,"name":"Ava Mauser","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Ava","middleName":"","lastName":"Mauser","suffix":""},{"id":512865816,"identity":"7a477c79-5b29-4fd8-91ad-f0e05ea14035","order_by":5,"name":"Claire Tronrud","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Claire","middleName":"","lastName":"Tronrud","suffix":""},{"id":512865817,"identity":"50db6787-7b31-4fa8-a8c3-fcc0179d2a67","order_by":6,"name":"Ziwen Zhu","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Ziwen","middleName":"","lastName":"Zhu","suffix":""},{"id":512865818,"identity":"fffb9a3c-ec22-455e-94b7-438cbd505cfc","order_by":7,"name":"Sadhakshi Raghuram","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Sadhakshi","middleName":"","lastName":"Raghuram","suffix":""},{"id":512865819,"identity":"4e5bc0c8-1b33-4042-b246-422e8e6fbbf9","order_by":8,"name":"Maya Sheth","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Maya","middleName":"","lastName":"Sheth","suffix":""},{"id":512865820,"identity":"ec947565-7a60-43e8-afc1-3716971d731f","order_by":9,"name":"Jorge Armando Pena Agudelo","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Jorge","middleName":"Armando Pena","lastName":"Agudelo","suffix":""},{"id":512865821,"identity":"15a00470-97ae-405b-9fec-35b62eb3240e","order_by":10,"name":"Julio Zelaya","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Julio","middleName":"","lastName":"Zelaya","suffix":""},{"id":512865822,"identity":"292bc391-b229-46d0-bbc7-aa4d8060af10","order_by":11,"name":"Ayman Taher","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Ayman","middleName":"","lastName":"Taher","suffix":""},{"id":512865823,"identity":"0d1086f6-c144-4781-b9de-ea0dc3d933f7","order_by":12,"name":"Padma Kadiyala","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Padma","middleName":"","lastName":"Kadiyala","suffix":""},{"id":512865824,"identity":"b6e45199-71c5-4ef6-bd56-2d96b1a11b14","order_by":13,"name":"Stephen Carney","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Stephen","middleName":"","lastName":"Carney","suffix":""},{"id":512865825,"identity":"ea2e21c6-f00b-406a-bd57-2a5be11f210e","order_by":14,"name":"Maria Garcia-Fabiani","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Maria","middleName":"","lastName":"Garcia-Fabiani","suffix":""},{"id":512865826,"identity":"9b00e00c-40a8-479a-89ce-fdeb47998060","order_by":15,"name":"Andrea Comba","email":"","orcid":"https://orcid.org/0000-0002-3398-5753","institution":"The University of Alabama at Birmingham","correspondingAuthor":false,"prefix":"","firstName":"Andrea","middleName":"","lastName":"Comba","suffix":""},{"id":512865827,"identity":"7ab77c6e-b290-4517-9379-4b44a5174bda","order_by":16,"name":"Mahmoud Alghamri","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Mahmoud","middleName":"","lastName":"Alghamri","suffix":""},{"id":512865828,"identity":"64b209b2-8b33-497e-9e51-0a4761b65033","order_by":17,"name":"Brandon McClellan","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Brandon","middleName":"","lastName":"McClellan","suffix":""},{"id":512865832,"identity":"5064e759-1b58-4300-ab38-a307c27d47a0","order_by":18,"name":"Zeribe Nwosu","email":"","orcid":"","institution":"Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University; Department of Molecular Biology and Genetics, Cornell University","correspondingAuthor":false,"prefix":"","firstName":"Zeribe","middleName":"","lastName":"Nwosu","suffix":""},{"id":512865837,"identity":"596fc889-a1fa-4f29-b490-e905d9170d88","order_by":19,"name":"Hanna Hong","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Hanna","middleName":"","lastName":"Hong","suffix":""},{"id":512865841,"identity":"57e4f369-43de-47ed-9101-0beeb051f94a","order_by":20,"name":"Peter Sajjakulnukit","email":"","orcid":"https://orcid.org/0000-0002-8556-7481","institution":"University of Michigan–Ann Arbor","correspondingAuthor":false,"prefix":"","firstName":"Peter","middleName":"","lastName":"Sajjakulnukit","suffix":""},{"id":512865843,"identity":"55a33147-ac9c-417c-9ffc-d21554eec8c5","order_by":21,"name":"Tingting Qin","email":"","orcid":"","institution":"Department of Computational Medicine \u0026 Bioinformatics, University of Michigan Medical School","correspondingAuthor":false,"prefix":"","firstName":"Tingting","middleName":"","lastName":"Qin","suffix":""},{"id":512865844,"identity":"ad9d13a9-28f4-4ff3-baa9-31eb1e8afd0a","order_by":22,"name":"Maureen Sartor","email":"","orcid":"https://orcid.org/0000-0001-6155-5702","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Maureen","middleName":"","lastName":"Sartor","suffix":""},{"id":512865846,"identity":"51a2e21f-cafe-4a2f-b8a0-46d328da5f69","order_by":23,"name":"Mats Ljungman","email":"","orcid":"https://orcid.org/0000-0003-1553-6695","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Mats","middleName":"","lastName":"Ljungman","suffix":""},{"id":512865847,"identity":"183b403d-09fd-495d-8438-78548fe4a812","order_by":24,"name":"Joshua Welch","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Joshua","middleName":"","lastName":"Welch","suffix":""},{"id":512865848,"identity":"9d0ef328-8bc6-4eac-ac69-0301f2cc9946","order_by":25,"name":"Shi-Yuan Cheng","email":"","orcid":"https://orcid.org/0000-0003-1737-0588","institution":"Northwestern University","correspondingAuthor":false,"prefix":"","firstName":"Shi-Yuan","middleName":"","lastName":"Cheng","suffix":""},{"id":512865851,"identity":"32d9281a-87cb-415d-90d1-168740041cd0","order_by":26,"name":"Pedro Lowenstein","email":"","orcid":"","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Pedro","middleName":"","lastName":"Lowenstein","suffix":""},{"id":512865852,"identity":"b040be05-2b38-4519-9821-a1aef31343ae","order_by":27,"name":"Joerg Lahann","email":"","orcid":"https://orcid.org/0000-0002-3334-2053","institution":"University of Michigan–Ann Arbor","correspondingAuthor":false,"prefix":"","firstName":"Joerg","middleName":"","lastName":"Lahann","suffix":""},{"id":512865854,"identity":"4132efe0-66fe-402f-8bff-803dbd893a47","order_by":28,"name":"Costas Lyssiotis","email":"","orcid":"https://orcid.org/0000-0001-9309-6141","institution":"University of Michigan","correspondingAuthor":false,"prefix":"","firstName":"Costas","middleName":"","lastName":"Lyssiotis","suffix":""}],"badges":[],"createdAt":"2025-08-28 22:10:09","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7483444/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7483444/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":91049415,"identity":"bcf4cab0-1ec1-4dac-b331-d16c42eb6ae1","added_by":"auto","created_at":"2025-09-11 06:36:36","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1753194,"visible":true,"origin":"","legend":"Article File","description":"","filename":"Autophagyfullmanuscript08.27.25.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7483444/v1_covered_c2f5706e-d8c3-47cb-9843-2d3d9cdf32e3.pdf"},{"id":91048587,"identity":"2e513bb7-01e7-4dce-937f-1e48697ea134","added_by":"auto","created_at":"2025-09-11 06:20:33","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":15527,"visible":true,"origin":"","legend":"Supplementary Table 1","description":"","filename":"AutophagyTableS1forF1B.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-7483444/v1/96736bb7a38fe4ce706f2bec.xlsx"},{"id":91048588,"identity":"bbc9465d-db86-4632-b3eb-df5c8cc102ab","added_by":"auto","created_at":"2025-09-11 06:20:33","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":15886,"visible":true,"origin":"","legend":"Supplementary Table 2","description":"","filename":"AutophagyTableS2forF1C.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-7483444/v1/435e433d5fcb38e987ad8450.xlsx"},{"id":91048591,"identity":"ec3b0875-f5e2-495b-98b1-ba1df4553809","added_by":"auto","created_at":"2025-09-11 06:20:33","extension":"pdf","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":4316404,"visible":true,"origin":"","legend":"Supplementary Methods and Figures","description":"","filename":"AutophagySupplementalmanuscript08.28.25.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7483444/v1/503e75338daebe7ae753d2b5.pdf"}],"financialInterests":"\u003cb\u003eYes\u003c/b\u003e there is potential Competing Interest.\nIn the past three years, C.A.L. has consulted for Astellas Pharmaceuticals, Odyssey Therapeutics, Third Rock Ventures, and T-Knife Therapeutics, and is an inventor on patents pertaining to Kras regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1-ME1 pathway as a therapeutic approach (US Patent No: 2015126580-A1, 05/07/2015; US Patent No: 20190136238, 05/09/2019; International Patent No: WO2013177426-A2, 04/23/2015). All other authors declare that there is no conflict of interest regarding the publication of this article.","formattedTitle":"Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-7483444/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7483444/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Mutant isocitrate dehydrogenase 1 (mIDH1) catalyzes 2-hydroxyglutarate production which leads to epigenetic reprogramming. RNA-seq, scRNA-seq, and ChIP-seq analysis revealed that human and mouse mIDH1 gliomas exhibit downregulated gene ontologies (GOs) related to mitochondrial metabolism and upregulated autophagy-related GOs. Decreased mitochondrial metabolism was accompanied by decreased glycolysis, rendering autophagy a source of energy in mIDH1 gliomas. Human and mouse mIDH1 glioma cells exhibited increased expression of autophagy-related proteins and enhanced LC3 I/II conversion, indicating augmented autophagy. Inhibiting autophagy in vivo by administration of synthetic protein nanoparticles encapsulating siRNA targeting Atg7 sensitized mIDH1 glioma cells to radiation, resulting in tumor regression, long-term survival, and immunological memory. This work uncovered autophagy as a critical pathway for survival in mIDH1 gliomas and its inhibition elicits radiosensitivity in vitro in human and mouse mIDH1 glioma cells, and in vivo in mIDH1 mouse models. Thus, autophagy inhibition emerges as an attractive therapeutic target for mIDH1 gliomas.","manuscriptTitle":"Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-09-11 06:20:28","doi":"10.21203/rs.3.rs-7483444/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"7f61b3bf-32bc-4385-94fc-7cf970bf0ffd","owner":[],"postedDate":"September 11th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[{"id":54476290,"name":"Biological sciences/Cancer/CNS cancer"},{"id":54476291,"name":"Biological sciences/Cancer/Cancer therapy/Radiotherapy"},{"id":54476292,"name":"Biological sciences/Cancer/Cancer therapy/Targeted therapies"}],"tags":[],"updatedAt":"2026-04-24T23:45:42+00:00","versionOfRecord":[],"versionCreatedAt":"2025-09-11 06:20:28","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7483444","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7483444","identity":"rs-7483444","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00